BRIEFS.
- Published in:
- Bio-IT World, 2003, v. 2, n. 11, p. 14
- Publication type:
- Article
Works matching DE "DYNAVAX Technologies Corp."
Results: 10
1
2
Boosting our best shot.
- Published in:
- Nature Medicine, 2009, v. 15, n. 9, p. 984, doi. 10.1038/nm0909-984
- By:
- Publication type:
- Article
3
GSK forms new alliances for anti-inflammatories.
- Published in:
- Chemistry & Industry, 2009, n. 3, p. 6
- By:
- Publication type:
- Article
4
Phase trials.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 1, p. 18
- Publication type:
- Article
5
NEWS.
- Published in:
- Clinical Infectious Diseases, 2016, v. 62, n. 7, p. i, doi. 10.1093/cid/ciw034
- By:
- Publication type:
- Article
6
15 May News.
- Published in:
- Clinical Infectious Diseases, 2013, v. 56, n. 10, p. i, doi. 10.1093/cid/cit180
- Publication type:
- Article
7
Heplisav's topline.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 10, p. 1058, doi. 10.1038/nbt1008-1058a
- By:
- Publication type:
- Article
8
Dynavax trial halted.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 5, p. 484, doi. 10.1038/nbt0508-484a
- By:
- Publication type:
- Article
9
Promotions, advancements.
- Published in:
- Nature Biotechnology, 2001, v. 19, n. 1, p. 88, doi. 10.1038/83599
- Publication type:
- Article
10
Immunostimulatory DNA - Dynavax: AIC, Amb a 1 Immunostimulatory Conjugate, HBV-ISS, ISS 1018, ISS DNA, ISS DNA - Dynavax, ISS1, ISS2.
- Published in:
- Drugs in R&D, 2002, v. 3, n. 3, p. 193
- Publication type:
- Article